title: Herceptin: HERalding a new era in breast cancer care but at what cost?
authors.forename: Lisa
authors.initials: L
authors.lastname: Hutchinson
authors.forename: Vincent T
authors.initials: VT
authors.lastname: DeVita
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006291:Health Policy; D006297:Health Services Accessibility; D006801:Humans; D000068878:Trastuzumab; D006113:United Kingdom
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab